Brigit Biofarmaka Teknologi Tbk. vs Suryamas Dutamakmur Tbk. — how do they compare? Brigit Biofarmaka Teknologi Tbk. trades at Rp252 (market cap 172.82B, 218.7K 24h volume), while Suryamas Dutamakmur Tbk. trades at Rp575 (market cap 2.74T, 81.4K 24h volume). The key difference: Suryamas Dutamakmur Tbk. is far larger — about 15.9× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (218.7K versus 81.4K). Which is the better fit depends on your goals.
| OBAT | SMDM | |
|---|---|---|
Market Cap | 172.82B | 2.74T |
Volume | 218.7K | 81.4K |
Lot | 2.19K | 814 |
Turnover | 53.51M | 46.68M |
Average Price | 244.66 | 573.51 |
Value | 53.51M | 46.68M |
Indicative Equilibrium Price | 252 | 575 |
Indicative Equilibrium Volume | 48 | 191 |
Trailing returns across standard periods
Latest headlines on both assets
PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →PT Suryamas Dutamakmur Tbk (the Company) was established based on notarial Deed No. 322, dated September 21, 1989 of Benny Kristianto, S.H., notary in Jakarta. PT. Suryamas Dutamakmur has a specific aim to participate in meeting the growing demand for quality residential development in the Greater Jakarta area.
Read more on SMDM →